Viscosupplementation Market Research Report –Forecast till 2030

Viscosupplementation Market: By Hyaluronic Acid Type (Stabilized Hyaluronic Acid), By Procedure Type (Three-Injection Procedure), By Application-Forecast till 2030

ID: MRFR/HC/5788-CR | 137 Pages | Published By Kinjoll Dey on March 2019         

Viscosupplementation Market Speak to Analyst Request a Free Sample

Viscosupplementation market

global viscosupplementation market is expected to grow USD 4,760 Million at a CAGR of 11.32% from 2022 to 2030.

By Hyaluronic Acid Type Stabilized Hyaluronic Acid
By Procedure Type Three-Injection Procedure
Key Players
Companies Profiled   Allergan   Sanofi   Hoffmann-La Roche   Smith & Nephew Plc   Zimmer Biomet   Anika Therapeutics Inc.   Ferring B.V.   Bioventus   Fidia Farmaceutici S.P.A.   
Market Driving Forces   Rising Popularity Of Minimally Invasive Procedures   Increasing Geriatric Population
Request a Free Sample

Viscosupplementation Market Overview

The viscosupplementation market is anticipated to reach USD 4,760 Million by 2030 at 11.32% CAGR during the forecast period 2022-2030.Viscosupplements available in the market have shown clinical efficacy and are the most effective treatment for knee osteoarthritis. Osteoarthritis is a chronic painful degenerative joint disease and is the leading cause of chronic disability. The rising prevalence of knee osteoarthritis, the growing demand for minimally invasive procedures, and the escalating geriatric population are some salient factors that can augment the viscosupplementation market size during the forecast period. On the other hand, stringent government regulations and the mounting denials of insurance for viscosupplementation products are likely to hamper the global viscosupplementation market growth during the assessment timeframe.

Even in middle-income and low-income countries, the global health community and governments have increasingly prioritized the treatment of numerous chronic diseases. As a result, the desire for proper treatment and cure to meet the global osteoarthritis load has increased dramatically, resulting in a surge in the use and adoption of viscosupplementation. Because the older population is prone to several musculoskeletal illnesses, including osteoarthritis, the global geriatric population would increase the growth of the investigated segment over the projection period.

Impact of COVID-19

The outbreak of COVID-19 is expected to create a significant impact on the growth of the viscosupplementation global market. The imposition of lockdown for the prevention of COVID-19 is has brought a negative impact on the global viscosupplementation market. However, the key players of the viscosupplementation market are adopting various strategies that can make a significant contribution in uplifting the market in the coming period.

Market Dynamics

The growing preference for single injection treatment of osteoarthritis is expected to positively impact the market growth in the assessment period. The increasing adoption of a sedentary lifestyle, smoking, and changing lifestyle are some of the other salient causes that are resulting in osteoarthritis and osteoporosis among the expanding population. 


Increasing Incidence of Knee Osteoarthritis to Promote the Viscosupplementation Global Market

Knee osteoarthritis is one of the most common ailments prevalent among the geriatric population. The rising cases of cardiovascular diseases, depression, obesity, renal failure, hypertension, and gastrointestinal bleeding are expected to grow the demand for viscosupplement therapy, thereby augmenting the market during the assessment period.


Integration of Proprietary Technology to Offer Significant Opportunities

The established players of the market are focusing on developing cross-linked hyaluronic acid to provide instant relief from pain. The on-going advancement is expected to offer a significant opportunity to augment the viscosupplementation market share.


Lack of Efficiency to Hamper the Market

The lack of efficiency and the high prices associated with hyaluronic acid treatment are expected to hamper the market growth during the assessment period.


Safety of Products to Pose a Significant Challenge to the Market

The safety concerns associated to the product are likely to pose a significant challenge to the market expansion during the assessment period.

Market Segmentation

The Viscosupplementation Global Market is segmented into Procedure Type, Hyaluronic Acid Type, Application, and End-User.

By Procedure Type

The procedure type based segments of the global viscosupplementation market are single-injection procedure, three-injection procedure, and five-injection procedure. Among all, the three-injection procedure segment is expected to dominate the market due to the lower cost of these products and the shorter treatment regimen in comparison to five-injection procedure products. The single-injection procedure is predicted to acquire the second-largest market, followed by the five-injection procedure for the viscosupplements market. The three-injection procedure is the leading segment, which is likely to grow at the highest CAGR to reach USD 2602.58 million by the end of 2023.

By Hyaluronic Acids

The hyaluronic acid type based segments of the global viscosupplementation market are standard hyaluronic acid and stabilized hyaluronic acid. Between the two segments, the stabilized hyaluronic acid segment is expected to acquire the largest market share owing to the higher quality of the product.

By Application

The application-type based segments of the global viscosupplementation market are knee arthritis and hip osteoarthritis.  Between the two segments, the knee arthritis segment is expected to account for a larger market share than hip osteoarthritis.

By End-User

The end-user type based segments of the global viscosupplementation market are hospitals & clinics, and ambulatory surgical centers. Between the two, the hospitals & clinics segment is anticipated to procure a larger market share due to the increasing visit of osteoporosis patients in the hospitals & clinics.

Regional Analysis

North America to Expand at the Highest CAGR during the Review Period

As per the viscosupplementation global market report prepared by MRFR, North America is expected to dominate the global market while expanding at the highest CAGR during the assessment period. The growth of the region can be attributed to the growing demand for minimally invasive viscosupplementation procedures for the treatment of knee osteoarthritis. Furthermore, the presence of advanced healthcare infrastructure established key players, and increasing demand for viscosupplementation products are likely to propel the regional market.

APAC to Value USD 447.24 million by 2023

The Asia-Pacific region is expected to acquire the second-largest market share. APAC is estimated to procure a market value of USD 447.24 million while expanding at a CAGR of 10.48% by 2023. The low-cost manufacturing in India and China is likely to expedite the production facilities that can augment the regional market in the projection timeframe. Furthermore, the increasing initiatives taken by the developing countries to develop their healthcare infrastructure is likely to augment the regional trade during the projection timeframe.

Europe to Expand Owing to Rising Geriatric Population

Europe is anticipated to grow during the forecast period owing to the rising geriatric population. The market in the region is likely to show a significant rise owing to the growing product innovation in the coming period. Among all European countries, the UK is anticipated to make a notable contribution in augmenting the regional market.

MEA to Show Steady Growth during the Assessment Period

MEA is anticipated to show significant growth during the forecast period owing to the growing awareness and the increasing initiatives taken by the countries to develop their healthcare infrastructure.

Competitive Analysis

The market is highly fragmented, and the renowned players are adopting various expansion strategies such as; new product launches, joint ventures, acquisitions, and partnerships. These initiatives are likely to enhance market competition.

Key Players Profiled in the Report

  • Allergan

  • Sanofi

  • Hoffmann-La Roche

  • Smith & Nephew Plc

  • Zimmer Biomet

  • Anika Therapeutics Inc.

  • Ferring B.V.

  • Bioventus

  • Fidia Farmaceutici S.P.A.

  • Regen Lab SA


Recent News

Sep 2021 Viscosupplementation with hyaluronic acid, also known as "gel injections," is available at Vitality Healthcare. This medication can help reduce the discomfort of osteoarthritis while also delaying or avoiding knee replacement surgery. Medicare and many supplemental insurance plans approve this surgery. To understand more about this technique, Vitality is offering a free consultation.

Dec 2021 OrthogenRx, a leader in viscosupplementation therapy for the treatment of knee osteoarthritis (OA) pain, has agreed to be acquired by Avanos Medical, Inc. for $130 million in cash and up to $30 million in contingent cash consideration. The deal was finalized on January 20, 2022.Segmentation Table

Viscosupplementation Market, By Procedure Type

  • Single-Injection Procedure

  • Three-Injection Procedure

  • Five-Injection Procedure

Viscosupplementation Market, By Hyaluronic Acids

  • Standard Hyaluronic Acid

  • Stabilized Hyaluronic Acid

Viscosupplementation Market, By Application

  • Knee Arthritis

  • Hip Osteoarthritis

Viscosupplementation Market, By End-User

  • Hospitals & Clinics

  • Ambulatory Surgical centers

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 4,760 Million
  CAGR   11.32%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Procedure Type, Hyaluronic Acid Type, Application, and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Allergan, Sanofi, Hoffmann-La Roche, Smith & Nephew Plc, Zimmer Biomet, Anika Therapeutics Inc., Ferring B.V., Bioventus, Fidia Farmaceutici S.P.A., Regen Lab SA
  Key Market Opportunities   Growing Demand From Emerging Nations
  Key Market Drivers

  • Increasing Patient Pool Suffering From Knee Osteoarthritis
  • Rising Popularity Of Minimally Invasive Procedures
  • Increasing Geriatric Population

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Viscosupplementation is the process of injecting lubricating fluid such as hyaluronic acid into joints to ease the movement of the joint.

    The growing prevalence of arthritis is likely to be the major driver for the global viscosupplementation market.

    The global viscosupplementation market is expected to rise to a valuation of USD 4,760 Million during the forecast period.

    The global viscosupplementation market is expected to exhibit a solid 11.32% CAGR over the forecast period from 2022-2030.

    Leading players in the viscosupplementation market include Sanofi, F. Hoffman-La Roche, Zimmer Biomet, Smith & Nephew plc, Ferring BV, and Bioventus, among others.